HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Novo Nordisk Launches OTC HRT Treatment In UK

Executive Summary

The first hormone replacement therapy drug sold without a prescription in the UK is now available in Boots pharmacies across the country.

You may also be interested in...

Rx-to-OTC Switch Of Menopause Treatment Approved In UK

Women in the UK will soon have OTC access to a low-dose Hormone Replacement Therapy drug following the reclassification of Novo Nordisk's Gina.

British Consumers Are Ready To Self-Care – Or Are They?

A new survey from UK consumer healthcare industry association PAGB shows an increased willingness to self-care on the part of British consumers. However, a different survey from Perrigo shows pharmacists less sure about their customers' ability to self-care responsibly. 

HRA Pharma And Maxwellia To Launch The UK’s First OTC Daily Contraceptives

The UK's MHRA has approved the Rx-to-OTC switch of two identical progestogen-only contraceptive pills from HRA Pharma and Maxwellia. Hana and Lovima (both 75mcg desogestrel) will be launched at the end of the month. 


Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts